Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 86Breast Neoplasms 15Neoplasms 6Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Salivary Gland Neoplasms 2Prostate Adenocarcinoma 2Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Leiomyoma 2Hodgkin Disease 2Uveal Melanoma 1Uterine Neoplasms 1Urogenital Neoplasms 1Skin Neoplasms 1Skin Diseases 1Salivary Gland Neoplasm Duct 1Recurrence 1Rare Diseases 1Prostatic Diseases 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1PSA Level Greater Than Two 1Obesity, Morbid 1Newly Diagnosed Oligometastatic Prostate Cancer 1Neoplasms, Glandular and Epithelial 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Melanoma 1Lymphoma, Mantle-Cell 1

Interventions

Radiotherapy, Intensity-Modulated 3Cisplatin 2encorafenib 1binimetinib 1alovudine 1X-Rays 1Specimen Handling 1Radiotherapy 1Radiosurgery 1Radiation Dose Hypofractionation 1Platinum 1Nivolumab 1Metastasectomy 1Magnetic Resonance Spectroscopy 1Leuprolide 1Ipilimumab 1Goserelin 1Drug Therapy 1Docetaxel 1Axitinib 1Androgen Antagonists 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lymphatic Metastasis × Leuprolide × Clear all
NCT01076335 2016-09-19

Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
40 enrolled 3 charts
Genitourinary

Lymphatic Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡